PathoGene, Inc. is a private, seed-stage precision MedTech startup headquartered in Los Angeles, with R&D operations located in Monrovia, California. We are developing a sample-to-answer in vitro diagnostic medical device that detects and identifies all known microscopic human pathogens along with their antimicrobial resistance profiles on a single 6-hour test panel. To do this, we leverage robotic automation, third-generation DNA and RNA sequencing, and cloud computing technologies to report a molecular diagnosis to care providers and disease surveillance systems in real-time.
Our goal is to deliver the necessary diagnostic tools for doctors and medical staff to make optimal treatment decisions that can ultimately improve public health as a whole, and we believe that our sample-to-answer technology can become the global standard of care for diagnosing infectious diseases.
Company’s Keywords:
bioinformatics, thirdgeneration sequencing, cloud computing, wet lab automation, in vitro diagnostics, metagenomics, pathogenomics, machine learning, natural language processing, medical devices, big data, google cloud platform, nanopore sequencing, infectious disease diagnostics, web applications, sample preparation, library preparation, clinical diagnostics, serverless applications, nextflow, antimicrobial resistance profiling, precision medicine
<4
<2400000
<2020